166 related articles for article (PubMed ID: 23519958)
1. Self-reported quality of life in long-term survivors of childhood lymphoblastic malignancy treated with hematopoietic stem cell transplantation versus conventional therapy.
Sundberg KK; Wettergren L; Frisk P; Arvidson J
Pediatr Blood Cancer; 2013 Aug; 60(8):1382-7. PubMed ID: 23519958
[TBL] [Abstract][Full Text] [Related]
2. A French cohort of childhood leukemia survivors: impact of hematopoietic stem cell transplantation on health status and quality of life.
Berbis J; Michel G; Chastagner P; Sirvent N; Demeocq F; Plantaz D; Barlogis V; Contet A; Poirée M; Kanold J; Galambrun C; Baumstarck K; Chambost H; Auquier P
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1065-72. PubMed ID: 23618717
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age.
Perkins JL; Kunin-Batson AS; Youngren NM; Ness KK; Ulrich KJ; Hansen MJ; Petryk A; Steinberger J; Anderson FS; Baker KS
Pediatr Blood Cancer; 2007 Dec; 49(7):958-63. PubMed ID: 17474113
[TBL] [Abstract][Full Text] [Related]
4. Unrelated transplantation for poor-prognosis adult acute lymphoblastic leukemia: long-term outcome analysis and study of the impact of hematopoietic graft source.
Ferrá C; Sanz J; de la Cámara R; Sanz G; Bermúdez A; Valcárcel D; Rovira M; Serrano D; Caballero D; Espigado I; Morgades M; Heras I; Solano C; Duarte R; Barrenetxea C; García-Noblejas A; Díez-Martin JL; Iriondo A; Carreras E; Sierra J; Sanz MA; Ribera JM;
Biol Blood Marrow Transplant; 2010 Jul; 16(7):957-66. PubMed ID: 20144909
[TBL] [Abstract][Full Text] [Related]
5. [Autologous versus allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia].
Wang GR; Xu Y; Zou DH; Zhao YZ; Wang M; Han MZ; Feng SZ; Yan WW; Qiu LG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):544-8. PubMed ID: 16995310
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study.
Bunin N; Aplenc R; Kamani N; Shaw K; Cnaan A; Simms S
Bone Marrow Transplant; 2003 Sep; 32(6):543-8. PubMed ID: 12953124
[TBL] [Abstract][Full Text] [Related]
7. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
[TBL] [Abstract][Full Text] [Related]
8. Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation.
Frick E; Borasio GD; Zehentner H; Fischer N; Bumeder I
Psychooncology; 2004 Feb; 13(2):116-24. PubMed ID: 14872530
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with poor quality of life in survivors of childhood acute lymphoblastic leukemia and lymphoma.
Kanellopoulos A; Hamre HM; Dahl AA; Fosså SD; Ruud E
Pediatr Blood Cancer; 2013 May; 60(5):849-55. PubMed ID: 23335116
[TBL] [Abstract][Full Text] [Related]
10. Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia.
Zohren F; Czibere A; Bruns I; Fenk R; Schroeder T; Gräf T; Haas R; Kobbe G
Bone Marrow Transplant; 2009 Dec; 44(12):785-92. PubMed ID: 19430496
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in adult survivors after paediatric allo-SCT.
Löf CM; Winiarski J; Giesecke A; Ljungman P; Forinder U
Bone Marrow Transplant; 2009 Mar; 43(6):461-8. PubMed ID: 18936733
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.
El-Cheikh J; Crocchiolo R; Furst S; Stoppa AM; Ladaique P; Faucher C; Calmels B; Lemarie C; De Colella JM; Granata A; Coso D; Bouabdallah R; Chabannon C; Blaise D
Am J Hematol; 2013 May; 88(5):370-4. PubMed ID: 23460414
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experiences and review of the literature.
Yoshihara T; Morimoto A; Kuroda H; Imamura T; Ishida H; Tsunamoto K; Naya M; Hibi S; Todo S; Imashuku S
Bone Marrow Transplant; 2006 Jan; 37(1):25-31. PubMed ID: 16247416
[TBL] [Abstract][Full Text] [Related]
14. Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies.
Braamse AM; Gerrits MM; van Meijel B; Visser O; van Oppen P; Boenink AD; Cuijpers P; Huijgens PC; Beekman AT; Dekker J
Bone Marrow Transplant; 2012 Jun; 47(6):757-69. PubMed ID: 21725373
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
[TBL] [Abstract][Full Text] [Related]
16. Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument.
Wettergren L; Sprangers M; Björkholm M; Langius-Eklöf A
Psychooncology; 2008 Apr; 17(4):338-46. PubMed ID: 17614094
[TBL] [Abstract][Full Text] [Related]
17. Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience.
Hallböök H; Hägglund H; Stockelberg D; Nilsson PG; Karlsson K; Björkholm M; Linderholm M; Wahlin A; Linder O; Smedmyr B;
Bone Marrow Transplant; 2005 Jun; 35(12):1141-8. PubMed ID: 15834433
[TBL] [Abstract][Full Text] [Related]
18. Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant.
Corvò R; Zeverino M; Vagge S; Agostinelli S; Barra S; Taccini G; Van Lint MT; Frassoni F; Bacigalupo A
Radiother Oncol; 2011 Mar; 98(3):382-6. PubMed ID: 21339008
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic cell transplantation in acute lymphoblastic leukemia: better long term event-free survival with conditioning regimens containing total body irradiation.
Granados E; de La Cámara R; Madero L; Díaz MA; Martín-Regueira P; Steegmann JL; Arranz R; Figuera A; Fernández-Rañada JM
Haematologica; 2000 Oct; 85(10):1060-7. PubMed ID: 11025598
[TBL] [Abstract][Full Text] [Related]
20. Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up.
Shimoni A; Hardan I; Ayuk F; Schilling G; Atanackovic D; Zeller W; Yerushalmi R; Zander AR; Kroger N; Nagler A
Cancer; 2010 Aug; 116(15):3621-30. PubMed ID: 20564132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
